Loading dendritic cells from HIV-1 infected patients with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses

por Climent, N, Munier, S, Piqué, N, García, F, Pavot, V, León, A, Primard, C, Miralles, L, Rovira, C, Casanova, V, McCormick, P, Gatell, JM, Verrier, B, Gallart, T
Publicado 2012

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)

por Gil, C, Climent, N, Hurtado, C, Nieto, S, García, F, León, A, Maite, G, Dalmau, J, Pumarola, T, Almela, M, Martinez-Picado, J, Zamora, L, Miró, JM, Gallart, T, Gatell, JM
Publicado 2009